PTBP1-mediated repression of neuron-specific CDC42 splicing constitutes a genomic alteration-independent,
Junjie Yang1, Jing Feng2, Jing Lv1
1Department of Biology, Beijing Key Laboratory of Gene Resource and Molecular Development, and Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, School of Life Sciences , Beijing Normal University, Beijing, China.
Abstract:
Gene co-expression networks may encode hitherto inadequately recognized vulnerabilities for adult gliomas. By identifying evolutionally conserved gene co-expression modules around EGFR (EM) or PDGFRA (PM), we recently proposed an EM/PM classification scheme, which assigns IDH-wildtype glioblastomas (GBM) into the EM subtype committed in neural stem cell compartment, IDH-mutant astrocytomas and oligodendrogliomas into the PM subtype committed in early oligodendrocyte lineage. Here, we report the identification of EM/PM subtype-specific gene co-expression networks and the characterization of hub gene polypyrimidine tract-binding protein 1 (PTBP1) as a genomic alteration-independent vulnerability in IDH-wildtype GBM. Supervised by the EM/PM classification scheme, we applied weighted gene co-expression network analysis to identify subtype-specific global gene co-expression modules. These gene co-expression modules were characterized for their clinical relevance, cellular origin and conserved expression pattern during brain development. Using lentiviral vector-mediated constitutive or inducible knockdown, we characterized the effects of PTBP1 on the survival of IDH-wildtype GBM cells, which was complemented with the analysis of PTBP1-depedent splicing pattern and overexpression of splicing target neuron-specific CDC42 (CDC42-N) isoform. Transcriptomes of adult gliomas can be robustly assigned into 4 large gene co-expression modules that are prognostically relevant and are derived from either malignant cells of the EM/PM subtypes or tumor microenvironment. The EM subtype is associated with a malignant cell-intrinsic gene module involved in pre-mRNA splicing, DNA replication and damage response, and chromosome segregation, and a microenvironment-derived gene module predominantly involved in extracellular matrix organization and infiltrating immune cells. The PM subtype is associated with two malignant cell-intrinsic gene modules predominantly involved in transcriptional regulation and mRNA translation, respectively. Expression levels of these gene modules are independent prognostic factors and malignant cell-intrinsic gene modules are conserved during brain development. Focusing on the EM subtype, we identified PTBP1 as the most significant hub for the malignant cell-intrinsic gene module. PTBP1 is not altered in most glioma genomes. PTBP1 represses the conserved splicing of CDC42-N. PTBP1 knockdown or CDC42-N overexpression disrupts actin cytoskeleton dynamics, causing accumulation of reactive oxygen species and cell apoptosis. PTBP1-mediated repression of CDC42-N splicing represents a potential genomic alteration-independent, developmentally conserved vulnerability in IDH-wildtype GBM.
Insights
New research identifies polypyrimidine tract-binding protein 1 (PTBP1) as a key vulnerability in IDH-wildtype glioblastoma (GBM). PTBP1 regulates splicing, impacting cell survival and offering a potential therapeutic target independent of genomic alterations.
Area of Science:
- Neuro-oncology
- Molecular biology
- Genomics
Background:
- Gene co-expression networks offer insights into adult glioma vulnerabilities.
- An EM/PM classification scheme categorizes gliomas based on conserved gene modules and cellular origin.
Purpose of the Study:
- To identify EM/PM subtype-specific gene co-expression networks.
- To characterize polypyrimidine tract-binding protein 1 (PTBP1) as a vulnerability in IDH-wildtype glioblastoma (GBM).
Main Methods:
- Weighted gene co-expression network analysis (WGCNA) to identify subtype-specific modules.
- Lentiviral vector-mediated knockdown of PTBP1 in IDH-wildtype GBM cells.
- Analysis of PTBP1-dependent splicing patterns and CDC42-N isoform expression.
Main Results:
- Adult gliomas were assigned into 4 prognostically relevant gene co-expression modules.
- The EM subtype showed modules related to splicing, DNA replication, and immune cells; the PM subtype showed modules for transcriptional regulation and mRNA translation.
- PTBP1 was identified as a key hub gene in the EM subtype, repressing the splicing of CDC42-N, which impacts cell survival.
Conclusions:
- PTBP1-mediated repression of CDC42-N splicing is a potential genomic alteration-independent vulnerability in IDH-wildtype GBM.
- This finding highlights conserved, developmentally relevant therapeutic targets in adult gliomas.


